6 comments

  1. The company’s shares, which rose over 4% in premarket trading
    earlier after its pain drug and birth control patch succeeded in late-stage
    studies, were up 1.4%, after Viatris reported a goodwill impairment charge of $2.9 billion.

發佈留言

發佈留言必須填寫的電子郵件地址不會公開。 必填欄位標示為 *

*
*